Category: Peptide Research

Research Use Only. Tesamorelin is a research peptide for laboratory use only. Not for human consumption.

Buy Tesamorelin 10mg — Research Grade, 99% Purity

Peppy University supplies research-grade Tesamorelin 10mg at 99% purity with HPLC documentation — third-party tested for consistent and reproducible laboratory results.

Tesamorelin Research Background

Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) with enhanced plasma stability. It is FDA-approved for HIV-associated lipodystrophy (marketed as Egrifta), making it one of the most well-documented GHRH analogs in the research literature. Laboratory studies have examined its effects on GH secretion, visceral fat reduction, IGF-1 axis activation, and metabolic regulation.

Metabolic Research Stack

Tesamorelin is frequently studied alongside GLP receptor peptides in comprehensive metabolic protocols. The Metabolic Stack combines Tesamorelin 10mg + GLP-3 30mg (Retatrutide) + Reconstitution Solution at $275.

Specifications

• Size: 10mg per vial
• Purity: 99% (HPLC verified)
• Price: $79.00
• Storage: -20°C, protected from light

→ Buy Tesamorelin 10mg at Peppy University

For laboratory research use only. Not for human consumption. Research Use Only.

Research Use Only. Semaglutide is a research peptide for laboratory use only. Not for human consumption or therapeutic application.

Buy Semaglutide for Research — 99% Purity, HPLC Verified

Peppy University supplies research-grade Semaglutide in 5mg and 10mg vials, third-party tested at 99% purity with full HPLC documentation. Available for qualified research applications.

Semaglutide Research Sizes Available

• Semaglutide 5mg — $75 | Standard research size
• Semaglutide 10mg — $110 | Extended research protocols

Semaglutide Research Background

Semaglutide is a GLP-1 receptor agonist (the active compound in Ozempic and Wegovy) that has been extensively studied for insulin secretion, glucagon suppression, gastric motility, and appetite regulation. It is the most well-characterized GLP peptide in the research literature, producing approximately 15-17% mean body weight reduction in clinical trials — making it the gold-standard baseline comparator for GLP research.

GLP Peptide Comparison

Peppy University carries the full GLP peptide research progression:

• Semaglutide (GLP-1 only) — $75 / $110
• Tirzepatide (GLP-1 + GIP) — $110 / $200
• GLP-3 Retatrutide (GLP-1 + GIP + Glucagon) — $70 / $189

Specifications

• Form: Lyophilized powder
• Purity: 99% (HPLC verified)
• Storage: -20°C, protected from light and moisture
• Sizes: 5mg ($75) and 10mg ($110)

→ Buy Semaglutide at Peppy University

For laboratory research use only. Not for human consumption. Research Use Only.

Research Use Only. Tirzepatide is a research peptide for laboratory use only. Not for human consumption or therapeutic application.

Buy Tirzepatide for Research — 99% Purity, HPLC Verified

Peppy University supplies research-grade Tirzepatide in 10mg and 30mg vials, third-party tested at 99% purity with full HPLC documentation. Available without prescription for qualified research applications.

Tirzepatide Research Sizes Available

• Tirzepatide 10mg — $110 | Ideal for dose-response studies and initial research protocols
• Tirzepatide 30mg — $200 | Best value per mg for extended research programs

Why Tirzepatide for Research?

Tirzepatide is a dual GLP-1/GIP receptor agonist developed by Eli Lilly (marketed as Mounjaro/Zepbound). In clinical trials (SURMOUNT-1), it produced approximately 20-22% mean body weight reduction — making it one of the most studied compounds for metabolic research. As a dual agonist targeting both GLP-1 and GIP receptors, it enables research into pathways not accessible with GLP-1-only compounds like semaglutide.

Tirzepatide vs Semaglutide vs GLP-3 (Retatrutide)

• Semaglutide — GLP-1 only (~15% weight reduction in trials)
• Tirzepatide — GLP-1 + GIP dual agonist (~20-22% weight reduction)
• GLP-3 / Retatrutide — GLP-1 + GIP + Glucagon triple agonist (~24.2% weight reduction)

All three are available at Peppy University for comparative metabolic research. See the Metabolic Stack for bundle pricing.

Specifications

• Form: Lyophilized powder
• Purity: 99% (HPLC verified)
• Storage: -20°C, protected from light and moisture
• Sizes: 10mg ($110) and 30mg ($200)

→ Buy Tirzepatide at Peppy University

For laboratory research use only. Not for human consumption. Research Use Only.

Research Use Only. GLP-3 (Retatrutide) is a research peptide intended strictly for qualified laboratory personnel. Not for human consumption or therapeutic application. All preparation should follow institutional biosafety protocols.

Overview

Proper storage and reconstitution of GLP-3 (Retatrutide) is critical for maintaining peptide integrity and ensuring reproducible research outcomes. This guide outlines laboratory best practices for handling lyophilized GLP-3, consistent with standard research peptide protocols.

Storage of Lyophilized GLP-3

GLP-3 is supplied in lyophilized (freeze-dried) powder form. Proper storage conditions are essential to preserve structural integrity:

• Long-term storage: -20°C in a dry, dark environment
• Short-term storage (under 4 weeks): 2-8°C refrigeration is acceptable
• Protect from: Light, moisture, and repeated temperature fluctuations
• Shelf life: Lyophilized peptides stored at -20°C remain stable for 24+ months when properly sealed
• Do not: Store at room temperature for extended periods or expose to direct sunlight

Reconstitution Protocol

GLP-3 requires reconstitution with a suitable laboratory-grade diluent prior to research use. Standard protocol:

• Recommended diluent: Bacteriostatic water (0.9% benzyl alcohol) for multi-use vials, or sterile saline for single-use applications
• Reconstitution method: Add diluent slowly along the interior wall of the vial — do not inject directly onto the lyophilized powder
• Mixing: Gently swirl to dissolve — do not shake or vortex, as mechanical agitation can denature the peptide structure
• Reconstituted storage: 2-8°C, use within 28-30 days
• Freeze-thaw cycles: Avoid repeated freezing of reconstituted solution — aliquot into single-use volumes before freezing if extended storage is needed

Laboratory Handling Precautions

• Handle in a sterile environment — laminar flow hood or biosafety cabinet recommended
• Use sterile, single-use syringes and needles for all transfers
• Label vials with date of reconstitution and lot number for traceability
• Document all handling procedures per institutional research protocols
• Dispose of peptide materials according to your institution’s biohazard waste procedures

Quality Verification

All GLP-3 (Retatrutide) supplied by Peppy University is:

• Third-party tested via HPLC for purity verification (99%+)
• Supplied with Certificate of Analysis documentation
• Lyophilized using standard pharmaceutical-grade freeze-drying processes
• Lot-tracked for research traceability and compliance documentation

Sourcing GLP-3 for Your Lab

Peppy University supplies research-grade GLP-3 (Retatrutide) in two sizes for different research applications:

• GLP-3 10mg — suitable for initial dose-response studies and smaller research protocols
• GLP-3 30mg — best value for extended research protocols requiring higher total peptide volume

Both available with 99% purity, HPLC verified COA, and same-day processing with 2-3 day delivery.

All products at Peppy University are intended strictly for laboratory and scientific research purposes only. Not for human consumption. Research Use Only.

Research Use Only. All compounds discussed are intended strictly for laboratory and scientific research. Not for human consumption or therapeutic application.

Overview: The GLP Peptide Landscape in 2026

The GLP receptor agonist family has become one of the most studied areas in metabolic research. Three generations of compounds now exist for laboratory investigation — each targeting a different combination of metabolic receptors. Understanding the mechanistic differences between Semaglutide, Tirzepatide, and GLP-3 (Retatrutide) is essential for designing effective preclinical research protocols.

Receptor Targeting: The Core Difference

The fundamental distinction between these three compounds is which receptors they activate:

• Semaglutide — GLP-1 receptor agonist only (single agonist)
• Tirzepatide — GLP-1 + GIP dual receptor agonist
• GLP-3 / Retatrutide — GLP-1 + GIP + Glucagon triple receptor agonist

Each additional receptor target introduces a new metabolic pathway into the research model, which is why the compounds show progressively different outcomes in preclinical and clinical studies.

Semaglutide in Research

Semaglutide is a GLP-1 receptor agonist that has been studied extensively for its effects on insulin secretion, glucagon suppression, gastric emptying, and appetite regulation. In clinical trials, semaglutide has demonstrated approximately 15-17% mean body weight reduction at maximum doses. It remains the most well-characterized GLP peptide in the research literature, making it a strong baseline comparator for newer compounds.

Key research applications: GLP-1 receptor pharmacology, insulin secretion models, appetite signaling, gastric motility studies.

Available at Peppy University: Semaglutide 5mg and 10mg

Tirzepatide in Research

Tirzepatide adds GIP receptor agonism to the GLP-1 framework. The GIP receptor component contributes enhanced insulin response and adipose tissue signaling that GLP-1 alone does not produce. Clinical trials showed approximately 20-22% mean body weight reduction — meaningfully higher than semaglutide — attributed in part to the complementary GIP pathway.

Key research applications: Dual receptor agonism studies, comparative GLP-1 vs GIP pathway investigation, insulin sensitivity models, adipose tissue metabolism research.

Available at Peppy University: Tirzepatide 10mg and 30mg

GLP-3 (Retatrutide) in Research

GLP-3 — Peppy University’s research designation for Retatrutide — adds the glucagon receptor as the third target. The glucagon receptor component increases energy expenditure and drives hepatic fat oxidation, mechanisms not activated by either semaglutide or tirzepatide. Phase 2 JAMA data showed approximately 24.2% mean body weight reduction at 48 weeks on the highest studied dose, with no plateau observed through the full study duration.

Key research applications: Triple receptor agonism studies, hepatic fat oxidation models, energy expenditure research, comparative single vs dual vs triple agonist protocols.

Available at Peppy University: GLP-3 10mg and GLP-3 30mg

Side-by-Side Research Comparison

Compound	Receptors Targeted	Phase 2/3 Weight Reduction	Unique Research Value
Semaglutide	GLP-1	~15-17%	Most characterized baseline; GLP-1 pharmacology gold standard
Tirzepatide	GLP-1 + GIP	~20-22%	GIP pathway contribution; dual agonist comparative studies
GLP-3 (Retatrutide)	GLP-1 + GIP + Glucagon	~24.2%	Glucagon receptor addition; hepatic fat; energy expenditure models

Which Compound for Your Research Protocol?

The choice depends on your research endpoints:

• GLP-1 receptor pharmacology → Semaglutide is the established reference compound
• Dual agonist or GIP pathway studies → Tirzepatide adds the GIP variable
• Triple agonism, glucagon pathway, or maximum metabolic effect studies → GLP-3 (Retatrutide) targets all three receptors
• Comparative studies across all three generations → Peppy University carries all three compounds for side-by-side protocol design

All compounds are available individually or as part of the Metabolic Stack at Peppy University.

All products at Peppy University are intended strictly for laboratory and scientific research purposes only. Not for human consumption. Research Use Only. Information presented references published peer-reviewed literature and is not medical advice.